Mineralocorticoid Receptor (MR) Antagonist (Eplerenone) vs Amlodipine and STRIATIN

NCT03683069 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Hypertension
Genetics Hypertension

Interventions

DRUG: Eplerenone vs Amlodipine

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]